Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02939274
Title An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne) for the Treatment of Cutaneous Metastases of Breast Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rogers Sciences Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.